Organism name | Laurus nobilis |
---|---|
Genus | Laurus |
Family | Lauraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Laurus nobilis |
---|---|
Linked NCBI taxonomy ID | 85223 |
Linked level | species |
Family in NCBI taxonomy | Lauraceae |
---|---|
ID | 3433 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Magnoliophyta |
---|---|
ID | 3398 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005374 |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 | |
C00009074 |
Procyanidin B7
/ Catechin-(4beta->6)-catechin |
CHEMBL506487
CHEMBL502984 CHEMBL451115 |
No. 16 | No. 19 | ||||
C00009077 |
Procyanidin B2
/ Epicathechin-(4beta->8)-epicathechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
C479580
|
20 / 7 / 8 | 10 / 0 | No. 16 | No. 19 | |
C00009076 |
Procyanidin B5
/ Epicatechin-(4beta-6)-epicatechin |
CHEMBL506487
CHEMBL502984 CHEMBL451115 |
No. 16 | No. 19 | ||||
C00002935 |
Procyanidin B4
/ Catechin-(4alpha->8)-epicatechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
20 / 7 / 8 | No. 16 | No. 19 | |||
C00001790 |
Actinodaphnine
/ (+)-Actinodaphnine / 1,2-Methylenedioxy-9-hydroxy-10-methoxynoraporphine |
CHEMBL518088
CHEMBL1588263 |
C060992
|
30 / 32 / 24 | No. 20 | No. 4 | ||
C00000956 |
(-)-Epicatechin
|
CHEMBL80941
CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
85 / 58 / 54 | No. 52 | No. 14 | |||
C00000947 |
D-Catechol
/ D-Catechin / Teafuran 30A / (+)-Catechin / Dexcyanidanol / (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol |
CHEMBL80941
CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
D002392
|
85 / 58 / 54 | 91 / 13 | No. 52 | No. 14 | |
C00048930 |
(+)-Epigallocatechin
|
CHEMBL47386
CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 |
26 / 17 / 29 | No. 52 | No. 14 | |||
C00008817 |
Gallocatechin
/ (+)-Gallocatechin / (+)-Gallocatechol / (2R,3S)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol |
CHEMBL47386
CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 |
26 / 17 / 29 | No. 52 | No. 14 | |||
C00004565 |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 | |
C00003240 |
Costunolide
|
CHEMBL86416
CHEMBL190377 CHEMBL1575037 |
C002602
|
10 / 7 / 15 | 0 / 3 | No. 107 | No. 38 | |
C00013775 |
Kaempferol 3-(2'',4''-di-(Z)-p-coumaroylrhamnoside)
/ 3-[[6-Deoxy-2,4-bis-O-[(2Z)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-alpha-L-mannopyranosyl]oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL1642586
CHEMBL1797052 |
1 / 1 / 1 | No. 231 | ||||
C00003314 |
Laurenobiolide
|
No. 249 | No. 38 | |||||
C00000604 |
(-)-Secoisolariciresinol
|
CHEMBL368347
|
C060283
|
2 / 1 / 1 | 1 / 0 | No. 282 | No. 21 | |
C00029488 |
3beta-Chlorodehydrocostuslactone
|
No. 306 | No. 38 | |||||
C00011053 |
(-)-Sabinene
/ (-)-4(10)-Thujene |
CHEMBL452687
|
No. 1343 | No. 35 | ||||
C00010827 |
Dehydro-1,8-cineole
|
No. 2943 | ||||||
C00010839 |
6,8-Epoxy-p-menth-2-ene
/ 4,7,7-Trimethyl-6-Oxabicyclo[3.2.1]oct-2-ene |
No. 2943 | ||||||
C00000136 |
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00000604 C00000947 C00000956 C00002935 C00004565 C00009077 | 1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 C00008817 C00048930 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00000604 C00000947 C00000956 C00002935 C00004565 C00009077 | 0 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000947 C00000956 C00002935 C00004565 C00008817 C00009077 C00048930 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 C00008817 C00048930 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 C00008817 C00048930 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 C00000947 C00000956 C00001790 C00004565 C00008817 C00048930 | 4 / 3 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00000947 C00000956 C00003240 C00004565 C00008817 C00048930 | 0 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000947 C00000956 C00002935 C00004565 C00008817 C00009077 C00048930 | 3 / 3 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000947 C00000956 C00003240 C00004565 C00008817 C00048930 | 1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000947 C00000956 C00001790 C00004565 C00008817 C00048930 | 2 / 2 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00000947 C00000956 C00004565 C00008817 C00048930 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00000947 C00000956 C00002935 C00004565 C00009077 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000947 C00000956 C00004565 C00005374 C00008817 C00048930 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00000947 C00000956 C00002935 C00004565 C00009077 | 1 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 C00000947 C00000956 C00003240 C00008817 C00048930 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00000947 C00000956 C00002935 C00004565 C00009077 | 0 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000947 C00000956 C00001790 C00005374 C00008817 C00048930 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000947 C00000956 C00001790 C00003240 C00004565 | 1 / 2 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 | 1 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000136 C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000947 C00000956 C00004565 C00008817 C00048930 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00000947 C00000956 C00001790 C00004565 C00005374 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000947 C00000956 C00003240 C00008817 C00048930 | 2 / 3 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000947 C00000956 C00008817 C00048930 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00000947 C00000956 C00003240 C00004565 | 2 / 5 |
P41743 | Protein kinase C iota type | Iota | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00000947 C00000956 C00002935 C00009077 | 1 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00000947 C00000956 C00002935 C00009077 | 0 / 1 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00000947 C00000956 C00008817 C00048930 | 2 / 3 |
P05771 | Protein kinase C beta type | Alpha | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
Q02156 | Protein kinase C epsilon type | Eta | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00000947 C00000956 C00008817 C00048930 | 0 / 7 |
P02768 | Serum albumin | Secreted protein | C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00000947 C00000956 C00002935 C00009077 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00000947 C00000956 C00002935 C00009077 | 1 / 1 |
P56817 | Beta-secretase 1 | A1A | C00000947 C00000956 C00008817 C00048930 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001790 C00004565 C00005374 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000947 C00000956 C00004565 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000947 C00000956 C00001790 | 2 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000947 C00000956 C00001790 | 4 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000947 C00000956 C00001790 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00000947 C00000956 C00004565 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000136 C00000947 C00000956 | 1 / 2 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000947 C00000956 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000947 C00000956 | 3 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00001790 C00004565 | 11 / 10 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00000947 C00000956 C00004565 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00000947 C00000956 C00001790 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000947 C00000956 C00003240 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000947 C00000956 C00004565 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000136 C00003240 C00004565 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000947 C00000956 C00001790 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000947 C00000956 | 0 / 1 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00000947 C00000956 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000947 C00000956 | 1 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000947 C00000956 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000947 C00000956 | 5 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00004565 | 1 / 8 |
P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00002935 C00009077 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000947 C00000956 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000947 C00000956 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000947 C00000956 | 1 / 1 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00008817 C00048930 | 0 / 1 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000947 C00000956 | 0 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00000136 C00004565 | 1 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00008817 C00048930 | 1 / 4 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000947 C00000956 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000947 C00000956 | 3 / 0 |
P49327 | Fatty acid synthase | Transferase | C00000947 C00000956 | 0 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000947 C00000956 | 0 / 1 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 C00013775 | 1 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 C00004565 | 2 / 2 |
P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00002935 C00009077 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000947 C00000956 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001790 C00004565 | 1 / 1 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000947 C00000956 | 1 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000947 C00000956 | 1 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00004565 | 0 / 1 |
P00734 | Prothrombin | S1A | C00000947 C00000956 | 4 / 2 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000947 C00000956 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000136 C00004565 | 3 / 4 |
P07998 | Ribonuclease pancreatic | Enzyme | C00000947 C00000956 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000947 C00000956 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000947 C00000956 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000136 C00001790 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001790 C00005374 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000947 C00000956 | 3 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000947 C00000956 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000947 C00000956 | 3 / 0 |
P07711 | Cathepsin L1 | C1A | C00000947 C00000956 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000947 C00000956 | 5 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000947 C00000956 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00004565 C00005374 | 0 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 | 1 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000136 | 0 / 1 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000136 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 | 1 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001790 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P03956 | Interstitial collagenase | M10A | C00000136 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00003240 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00001790 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00001790 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00004565 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00004565 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 | 2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00004565 | 5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 | 1 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000136 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00004565 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001790 | 2 / 2 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 | 1 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 | 1 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00004565 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 | 2 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 | 2 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 | 2 / 0 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001790 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001790 | 1 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005374 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 | 1 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000136 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004565 | 1 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004565 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000136 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00004565 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000136 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 | 1 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000136 | 0 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 | 0 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00004565 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001790 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000136 | 2 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000136 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001790 | 1 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00004565 | 6 / 4 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000136 | 2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004565 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00001790 | 0 / 0 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 | 7 / 37 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | C00003240 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00004565 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005374 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001790 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000947
C00004565
C00009077
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00000947
C00004565
C00009077
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000947
C00004565
C00005374
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000947
C00004565
C00009077
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000947
C00004565
C00009077
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000947
C00004565
C00009077
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000947
C00004565
C00009077
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000947
C00004565
C00009077
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000947
C00004565
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000947
C00004565
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00000947
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000947
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000604
C00004565
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000947
C00004565
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000947
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000947
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00000947
C00004565
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00004565
C00005374
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000947
C00004565
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00000947
C00009077
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00000947
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
37618 |
C00004565
|
||
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004565
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00004565
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
110357 |
C00004565
|
||
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004565
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00004565
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00004565
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00004565
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00009077
|
4240 | MFGE8, BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM, OAcGD3S, SED1, SPAG10, hP47 | milk fat globule-EGF factor 8 protein |
C00009077
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00000947
|
302 | ANXA2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV | annexin A2 |
C00000947
|
393 | ARHGAP4, C1, RGC1, RhoGAP4, SrGAP4, p115 | Rho GTPase activating protein 4 |
C00000947
|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00000947
|
2683 | B4GALT1, B4GAL-T1, CDG2D, GGTB2, GT1, GTB, beta4Gal-T1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38) |
C00000947
|
56751 | BARHL1 | BarH-like homeobox 1 |
C00000947
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000947
|
388962 | BOLA3, MMDS2 | bolA family member 3 |
C00000947
|
79184 | BRCC3, BRCC36, C6.1A, CXorf53 | BRCA1/BRCA2-containing complex, subunit 3 (EC:3.1.2.15) |
C00000947
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000947
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00000947
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000947
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000947
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000947
|
930 | CD19, B4, CVID3 | CD19 molecule |
C00000947
|
975 | CD81, CVID6, S5.7, TAPA1, TSPAN28 | CD81 molecule |
C00000947
|
928 | CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29 | CD9 molecule |
C00000947
|
1054 | CEBPG, GPE1BP, IG/EBP-1 | CCAAT/enhancer binding protein (C/EBP), gamma |
C00000947
|
10978 | CLP1, HEAB, hClp1 | cleavage and polyadenylation factor I subunit 1 (EC:2.7.1.78) |
C00000947
|
10063 | COX17 | COX17 cytochrome c oxidase copper chaperone |
C00000947
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00000947
|
7913 | DEK, D6S231E | DEK oncogene |
C00000947
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00000947
|
2130 | EWSR1, EWS, bK984G1.4 | EWS RNA-binding protein 1 |
C00000947
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000947
|
2323 | FLT3LG, FL, FLT3L | fms-related tyrosine kinase 3 ligand |
C00000947
|
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00000947
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00000947
|
3054 | HCFC1, CFF, HCF-1, HCF1, HFC1, MRX3, VCAF | host cell factor C1 (VP16-accessory protein) |
C00000947
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000947
|
3232 | HOXD3, HOX1D, HOX4, HOX4A, Hox-4.1 | homeobox D3 |
C00000947
|
3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00000947
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha |
C00000947
|
9235 | IL32, IL-32alpha, IL-32beta, IL-32delta, IL-32gamma, NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd | interleukin 32 |
C00000947
|
3662 | IRF4, LSIRF, MUM1, NF-EM5 | interferon regulatory factor 4 |
C00000947
|
3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00000947
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00000947
|
4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00000947
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000947
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000947
|
4282 | MIF, GIF, GLIF, MMIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) |
C00000947
|
64975 | MRPL41, BMRP, MRP-L27, MRPL27, RPML27 | mitochondrial ribosomal protein L41 |
C00000947
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00000947
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00000947
|
4851 | NOTCH1, TAN1, hN1 | notch 1 |
C00000947
|
4869 | NPM1, B23, NPM | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
C00000947
|
5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00000947
|
5187 | PER1, PER, RIGUI, hPER | period circadian clock 1 |
C00000947
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000947
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00000947
|
7916 | PRRC2A, BAT2, D6S51, D6S51E, G2 | proline-rich coiled-coil 2A |
C00000947
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00000947
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00000947
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000947
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000947
|
6128 | RPL6, L6, SHUJUN-2, TAXREB107, TXREB1 | ribosomal protein L6 |
C00000947
|
6285 | S100B, NEF, S100, S100-B, S100beta | S100 calcium binding protein B |
C00000947
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000947
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00000947
|
7536 | SF1, BBP, D11S636, MBBP, ZCCHC25, ZFM1, ZNF162 | splicing factor 1 |
C00000947
|
6574 | SLC20A1, GLVR1, Glvr-1, PIT1, PiT-1 | solute carrier family 20 (phosphate transporter), member 1 |
C00000947
|
6699 | SPRR1B, CORNIFIN, GADD33, SPRR1 | small proline-rich protein 1B |
C00000947
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000947
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000947
|
6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00000947
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000947
|
6932 | TCF7, TCF-1 | transcription factor 7 (T-cell specific, HMG-box) |
C00000947
|
7083 | TK1, TK2 | thymidine kinase 1, soluble (EC:2.7.1.21) |
C00000947
|
943 | TNFRSF8, CD30, D1S166E, Ki-1 | tumor necrosis factor receptor superfamily, member 8 |
C00000947
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00000947
|
2829 | XCR1, CCXCR1, GPR5 | chemokine (C motif) receptor 1 |
C00000947
|
51042 | ZNF593, ZT86 | zinc finger protein 593 |
C00000947
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
Q14191 |
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P08581
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P00734
P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) P10415 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006943 | Hyperglycemia |
C00003240
C00004565 |
D001943 | Breast Neoplasms |
C00004565
C00000947 |
D050197 | Atherosclerosis |
C00004565
C00000947 |
D002471 | Cell Transformation, Neoplastic |
C00000947
|
D003921 | Diabetes Mellitus, Experimental |
C00003240
|
D009202 | Cardiomyopathies |
C00004565
|
D002318 | Cardiovascular Diseases |
C00004565
|
D007938 | Leukemia |
C00004565
|
D010024 | Osteoporosis |
C00004565
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D010146 | Pain |
C00005374
|
D011230 | Precancerous Conditions |
C00003240
|
D003556 | Cystitis |
C00000947
|
D056486 | Drug-Induced Liver Injury |
C00000947
|
D034381 | Hearing Loss |
C00000947
|
D006331 | Heart Diseases |
C00000947
|
D020138 | HYPERHOMOCYSTEINEMIA |
C00000947
|
D008107 | Liver Diseases |
C00000947
|
D017114 | Liver Failure, Acute |
C00000947
|
D008113 | Liver Neoplasms |
C00000947
|
D008325 | Mammary Neoplasms, Experimental |
C00000947
|
D009362 | Neoplasm Metastasis |
C00000947
|